Full Text View
Tabular View
No Study Results Posted
Related Studies
Selecting a Favorable KIR Donor in Unrelated HCT for AML
This study is currently recruiting participants.
Verified March 2013 by Masonic Cancer Center, University of Minnesota
Study NCT01288222   Information provided by Masonic Cancer Center, University of Minnesota

First Received on February 1, 2011.   Last Updated on March 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Myelogenous Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
KIR genotype
Unrelated donor transplant
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services